All necessary regulatory approvals have been obtained for the combination of Novozymes and Chr. Hansen

January 26, 2024 – Company announcement no. 1 Please see attachment.Contact informationInvestor RelationsDisa Tuominen +45 6038 5826dkditu@chr-hansen.comPress RelationsSanne Seyer-Hansen +45 6038 6207dksash@chr-hansen.comAttachment No. 1 All necessary regulatory approvals have been obtained

January 26, 2024 – Company announcement no. 1

Please see attachment.

Contact information

Investor Relations
Disa Tuominen
+45 6038 5826
dkditu@chr-hansen.com

Press Relations
Sanne Seyer-Hansen
+45 6038 6207
dksash@chr-hansen.com

Attachment

• No. 1 All necessary regulatory approvals have been obtained